Noramco News and Activities
Presence
Headquarters: United States (USA)
Siegfried is a company listed under the stock ticker SGFEF (CH).
Siegfried has a direct presence in 2 countries.
They are in:
- Pharmaceuticals67%
- Biotechnology33%
Acquisition, funding and merger involving Siegfried.
- Siegfried has acquired Noramco (posted on May 6 2026).
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Noramco
- Jim Mish, President and Chief Executive Officer
- Bill Grubb, Vice President, Business Development and Innovation
- Alan Majewski, Chief Financial Officer
Popular executive movements at Siegfried
- Christina Del Vecchio will join the company as Chief Legal Officer on Nov. 1, 2026 (posted on June 2 2026).
- Luca Dalla Torre, Chief Legal and Sustainability Officer, will leave the company on Nov. 1, 2026 (posted on June 2 2026).
- Reto Suter, Chief Financial Officer, will leave the company on Jul. 1, 2026 (posted on November 17 2025).
Click here to view some more movements at Siegfried
Create your alert
to follow the executive moves at Noramco.
Pharmaceuticals
Siegfried has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals (posted on July 7 2026).
- Novartis has announced the acquisition of Myricx Bio (posted on July 6 2026).
- Ipsen has announced the acquisition of Kartos Therapeutics (posted on July 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Noramco
Social media about Noramco
- Noramco on Wikipedia, Google News & Yahoo Finance
- Noramco on LinkedIn, X (Twitter) & YouTube
